Clinical Trial Update: Nitrocamptothecin in Treating Patients With Soft Tissue Sarcomas [Phase 2]

View source ↗

Summary

This is a completed Phase 2 trial of Nitrocamptothecin in patients with soft tissue sarcomas, including gastrointestinal stromal tumors and small intestine canc…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastrointestinal Stromal Tumor
• Small Intestine Cancer
• Soft Tissue Sarcoma

Drugs mentioned

• Nitrocamptothecin (nitrocamptothecin)

Snippet

Sponsor: Astex Pharmaceuticals, Inc. | Conditions: Gastrointestinal Stromal Tumor, Sarcoma | Phase 2 | Status: COMPLETED